[脉络膜上腔出血与系统性纤溶相关的急性青光眼]

[Suprachoroidal haemorrhage and acute glaucoma associated with systemic fibrinolysis].

作者信息

Asensio Sánchez V M, Pérez Flández F J, Carlos Bejarano J, Merino Núñez F

机构信息

Hospital General del INSALUD, Medina del Campo, Valladolid, España.

出版信息

Arch Soc Esp Oftalmol. 2002 Aug;77(8):459-61.

PMID:12185623

Abstract

PURPOSE/METHOD: To describe the clinical case of a patient with acute myocardial infarction and an ocular haemorrhage as a complication of the use of systemic thrombolytic agents.

RESULTS/CONCLUSIONS: A patient who received therapy with tissue plasminogen activator for an acute myocardial infarction developed three hours later a massive suprachoroidal haemorrhage with secondary acute angle closure. In patients who have undergone systemic thrombolytic agents, the presence of loss of vision and pain must alert to the possibility of secondary ocular haemorrhage. These patients may benefit from continuous control (Arch Soc Esp Oftalmol 2002; 77: 459-462).

摘要

目的/方法：描述一名急性心肌梗死患者使用全身溶栓剂后出现眼部出血并发症的临床病例。

结果/结论：一名接受组织纤溶酶原激活剂治疗急性心肌梗死的患者，三小时后发生大量脉络膜上腔出血并继发急性闭角型青光眼。在接受全身溶栓剂治疗的患者中，视力丧失和疼痛的出现必须警惕继发性眼部出血的可能性。这些患者可能受益于持续监测（《西班牙眼科协会杂志》2002年；77：459 - 462）。